University of Bratislava

Academic/Hospital

Also known as: CU in Bratislava, Faculty of Medicine, Pharmacobiochemical Laboratory of 3rd department of Medicine | HSCT Unit, University Children's Hospital Bratislava | University Hospital in Bratislava

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2007

Last known activity

Dec 1, 2013

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 2 trials)

Phase 3 (6 own, 0 via acquisition)

muromonab cd3
Anti-thymocyte Globulin (Rabbit)
fludarabine
thiotepa
etoposide
treosulfan

Other trials (1 own, 0 via acquisition)

l-carnosine

Indications

Studied for

Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Recent trials (2)

NCT02011100Study chairN/ADec 1, 2013
NCT01423500Overall official - principal investigatorPhase 3Jan 1, 2007

Details

Last known activity: Dec 1, 2013